Adamas announces declaratory judgment action filed by Osmotica related to approved OSMOLEX
Adamas announced that Osmotica Pharmaceuticals and Vertical Pharmaceuticals filed an action in Delaware federal court Feb. 16, 2018 requesting a declaratory judgment that Osmotica's newly-approved product OSMOLEX ER™ (amantadine) ER tablets does not infringe certain of Adamas' patents. February 19, 2018